Katherine Ruffner - Jul 12, 2021 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Medical Officer
Signature
/s/ Katherine Ruffner
Stock symbol
CRDF
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
4
Date filed
7/14/2021, 04:00 PM
Previous filing
Jul 13, 2021
Next filing
Mar 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +200K $0.00 200K Jul 12, 2021 Common Stock 200K $6.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% vest on 7/12/2022. The remainder vest in equal installments monthly for 36 months beginning on 8/12/2022 through 7/12/2025.